Catalyst Pharmaceuticals (CPRX) announced the appointment of Daniel Curran, MD, to its Board of Directors. Since March 2024, Curran has served as Managing Partner of Mountainfield Venture Partners
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPRX: